Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.71
14.05.24
€3.00
14.05.25
25.85%
15.05.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Insmed Inc.

Start price
Target price
Perf. (%)
€23.60
13.05.24
€15.00
13.05.25
0.00%
14.05.24

Could be very worthwhile Investment >20% year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.36
13.05.24
€2.00
13.05.25
14.74%
14.05.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
37.40%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.96
10.05.24
-
10.05.25
4.80%
11.05.24

Could be worthwhile Investment >10% per year
buy
Heartland Express Inc.

Start price
Target price
Perf. (%)
€10.20
03.05.24
€18.00
03.05.25
5.88%
13.05.24

Could be very worthwhile Investment >20% year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€2.47
02.05.24
€4.50
02.05.25
-16.88%
13.05.24

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€812.90
29.04.24
€1,000.00
29.04.25
-8.22%
11.05.24

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€17.72
29.04.24
€25.00
29.04.25
-9.36%
11.05.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€17.88
27.04.24
-
27.04.25
11.30%
11.05.24

Could be worthwhile Investment >10% per year
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
0.00%
11.05.24

Could be worthwhile Investment >10% per year
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
0.00%
11.05.24

Could be worthwhile Investment >10% per year
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
0.00%
11.05.24

Could be worthwhile Investment >10% per year
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
0.00%
11.05.24

Could be worthwhile Investment >10% per year
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
0.00%
11.05.24

Could be worthwhile Investment >10% per year
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
0.00%
11.05.24

Could be worthwhile Investment >10% per year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.28
27.04.24
€2.00
27.04.25
3.55%
13.05.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.68
24.04.24
-
24.04.25
4.63%
26.04.24

Could be worthwhile Investment >10% per year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-8.41%
27.04.24

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.50
19.04.24
-
19.04.25
-12.02%
10.05.24

Could be very worthwhile Investment >20% year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€3.06
19.04.24
-
19.04.25
-20.98%
10.05.24

Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year